Cardiovascular Implants Market Growth Accelerates: Strategic Forecast Predicts $36.69 Billion by 2029

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Cardiovascular Implants Industry Market Size Be by 2025?
In the last few years, the cardiovascular implants market has witnessed significant growth. Its size, which was $26.8 billion in 2024, is projected to expand to $28.86 billion by 2025, with a compound annual growth rate (CAGR) of 7.7%. Factors contributing to this progress during the historical period include an aging population and cardiovascular risk, lifestyle-related cardiovascular risk elements, enhancements in diagnostic technology, increased awareness and screening programs, along with government initiatives focused on cardiovascular health.

What's the Long-Term Growth Forecast for the Cardiovascular Implants Market Size Through 2029?
Over the next several years, robust growth is projected for the cardiovascular implants market, which is forecast to ballooning up to $36.69 billion by 2029 at a compound annual growth rate (CAGR) of 6.2%. This growth can be ascribed to factors such as the rise of personalized medicine approaches, the shift towards less invasive procedures, worldwide cooperation in cardiovascular research, the emphasis upon preventative measures in healthcare policies, and the focus on patient-oriented cardiovascular care. The forecast period boasts significant advancements such as the development of drug-eluting stents, the emergence of next-generation heart valves, the growing incorporation of Artificial Intelligence (AI), a renewed focus on minimally invasive implantation techniques, the creation of personalized and patient-specific implants, as well as the innovation of leadless pacemakers.

View the full report here:
https://www.thebusinessresearchcompany.com/report/cardiovascular-implants-global-market-report

What Are the Key Growth Drivers Fueling the Cardiovascular Implants Market Expansion?
The increasing incidence of heart-related ailments is anticipated to fuel the expansion of the cardiovascular implants market in the future. Heart disorders encompass a range of medical problems that impact the heart and blood vessels, such as coronary artery disease, heart failure, arrhythmias, and valve disorders. This surge in heart diseases like coronary artery disease and heart failure escalates the need for cardiovascular implants like stents and pacemakers for their treatment. Such implants aid the heart and blood flow in heart failure patients, ensure a regular heart rhythm, and monitor the heart rhythm. For example, a report produced by the British Heart Foundation (BHF), a UK-based charity dedicated to funding research and spreading awareness about heart and circulatory diseases, noted that around 7.6 million individuals in the UK are affected by heart and circulatory diseases as of September 2024. By 2030, the UK may see an increase of 1 million individuals affected by heart and circulatory diseases, which might further increase to 2 million by 2040, on top of the current figures. Hence, the escalating incidence of heart disorder is propelling the expansion of the cardiovascular implants market. As the population ages, the demand for cardiovascular implants is set to rise, boosting market growth. This demographic shift, marked by an increase in the population aged 60 and over, signifies an aging population trend. Cardiovascular implants offer effective management and treatment options for cardiovascular diseases seen in the elderly, enhancing their overall health, prolonging life, and supporting better quality of life. For instance, the World Health Organization, a US-based specialized health agency mentioned in a report in October 2022 that globally, one in every six individuals will be aged 60 or over by 2030, this figure is predicted to reach 2.1 billion by 2050. This growth in the aged population therefore, is leading the expansion of the cardiovascular implants market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13399&type=smp

What Are the Key Trends Driving Cardiovascular Implants Market Growth?
Leading firms in the cardiovascular implants market are prioritizing the utilization of advanced artificial intelligence (AI) technology to amplify their market profits and refine patient care and treatment accuracy. The progress in cardiac monitoring technology enables constant tracking and recordkeeping of a patient's cardiac activities for diagnosing and managing heart conditions. To provide an example, in June 2023, BIOTRONIK SE & Co. KG, a medical technology organization based in Germany, initiated the first global implementation of its BIOMONITOR IV implantable cardiac monitor (ICM). The BIOMONITOR IV is an advanced ICM that merges BIOTRONIK's SmartECG technology with AI, which reduces false-positive detections by 86% while preserving 98% of actual events. Besides its sophisticated AI, the BIOMONITOR IV offers multiple benefits for patients and healthcare workers, including extended battery life and wireless connectivity for seamless data transfer and remote monitoring, thereby reducing the need for regular face-to-face clinic appointments.

How Is the Cardiovascular Implants Market Segmented?
The cardiovascular implants market covered in this report is segmented -

1) By Product: Coronary Stent, Implantable Cardioverter Defibrillator (ICD), Heart Valve, Implanted Cardiac Pacemaker, Cardiac Resynchronization Therapy (CRT) Devices, Peripheral Stent
2) By Material: Metals and Alloys, Polymers, Biological Materials
3) By Application: Arrhythmias, Acute Myocardial Infarction, Myocardial Ischemia, Other Applications
4) By End-Users: Hospitals, Ambulatory Surgical Centers, Cardiac Centers

Subsegments:
1) By Coronary Stent: Drug-Eluting Stents, Bare-Metal Stents, Bioabsorbable Stents
2) By Implantable Cardioverter Defibrillator (ICD): Single-Chamber ICD, Dual-Chamber ICD, Biventricular ICD
3) By Heart Valve: Mechanical Heart Valves, Biological Heart Valves, Transcatheter Heart Valves
4) By Implanted Cardiac Pacemaker: Single-Chamber Pacemaker, Dual-Chamber Pacemaker, Biventricular Pacemaker
5) By Cardiac Resynchronization Therapy (CRT) Devices: CRT-P Devices (Pacemakers), CRT-D Devices (Defibrillators)
6) By Peripheral Stent: Carotid Artery Stents, Renal Artery Stents, Femoral Artery Stents

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=13399&type=smp

Which Companies Are Leading the Charge in Cardiovascular Implants Market Innovation?
Major companies operating in the cardiovascular implants market report are Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, B. Braun Melsungen AG, Edwards Lifesciences Corporation, W. L. Gore & Associates Inc., Cook Medical Incorporated, Teleflex Incorporated, Kyoto Medical Planning Co. Ltd., Abiomed Inc., Livanova PLC, BIOTRONIK SE & Co. KG, CryoLife Inc., Endologix Inc., Sorin Group, Berlin Heart GmbH, REVA Medical LLC., Syncardia Systems LLC, Elixir Medical Corporation, Fortimedix Surgical B.V., AMG International GmbH, CHF Solutions Inc., Proxy Biomedical Ltd., Calon Cardio-Technology Ltd., InspireMD Inc., Neovasc Inc., Shree Pacetronix Ltd., Vascutek Ltd (Terumo Corporation)

Which Regions Are Leading the Global Cardiovascular Implants Market in Revenue?
North America was the largest region in the cardiovascular implants market in 2024. The regions covered in the cardiovascular implants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13399

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.